ADPT as of Nov 1 · 04:48 ET

ADPTNasdaqBiological Products, (No Diagnostic Substances)

Adaptive Biotechnologies Corp · Brief

Next report

3 days

Nov 4 · after closeest.Q3 FY26

Earnings

Expected move

Inputs

±18.7%implied · report alone

21.6631.62

straddle ±18.8%

spot 26.64exp Nov 20ATM strike 25ATM straddle 5.90IV 117%

Oct 30 closereport share · term structurethin chain

Expected move

Inputs

Implied vs realized

8 reportsHistory

2 of 8≥ implied

avg implied: ±15.7%
avg realized: ±10.8%

Feb 11 '25±13.4%▼−3.21%×0.24

May 1 '25±13.4%▲+33.70%×2.52

Aug 5 '25±19.2%▲+5.79%×0.30

Q3 FY25±20.9%▼−11.54%×0.55

Jan 12 '26±13.5%▲+15.86%×1.18

Feb 5 '26±13.4%▼−4.25%×0.32

Q1 FY26±16.2%▲+4.72%×0.29

Q2 FY26±15.2%▲+7.18%×0.47

quarterimplied−35%0+35%realized×

Q2 FY26±15.2%▲+7.18%×0.47

Q1 FY26±16.2%▲+4.72%×0.29

Feb '26±13.4%▼−4.25%×0.32

Jan '26±13.5%▲+15.86%×1.18

Q3 FY25±20.9%▼−11.54%×0.55

Aug '25±19.2%▲+5.79%×0.30

2 older reports

May '25±13.4%▲+33.70%×2.52

Feb '25±13.4%▼−3.21%×0.24

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 4 report · est.

Bull2 of 4

6disclosed supplier and customer ties in SEC filingsSEC filings

299managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 4

6 of 8recent reports where the move came in under the options implied rangeEarnings history

5 of 23largest reporting managers that cut their stake in the latest quarter13F · Jun 30 '26

AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

ADPT report session

Suppliers 1

ILMNIllumina×0.26

× = co-movement · max 501dSource: SEC filings · market data

Latest changes

30 daysAll changes

Oct 21impliedImplied move: ±18.1% into Nov 4 earnings (Oct 21 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.